首页|期刊导航|中国药物经济学|益气温阳活血方联合标准疗法对冠状动脉粥样硬化性心脏病合并射血分数降低型心力衰竭患者心室重塑与生命质量的影响

益气温阳活血方联合标准疗法对冠状动脉粥样硬化性心脏病合并射血分数降低型心力衰竭患者心室重塑与生命质量的影响OA

Effect of the Yiqi Wenyang Huoxue Formula Combined with Standard Therapy on Ventricular Remodeling and Quality of Life in Patients with Coronary Atherosclerotic Heart Disease and Reduced Ejection Fraction Heart Failure

中文摘要英文摘要

目的 探讨益气温阳活血方联合标准疗法对冠状动脉粥样硬化性心脏病合并射血分数降低型心力衰竭患者心室重塑与生命质量的影响.方法 选取 2022 年 10 月至 2023 年 10 月遵义市中医院收治的冠状动脉粥样硬化性心脏病合并射血分数降低型心力衰竭患者123 例,采用随机分组的方式分为试验组与对照组,每组60 例.两组均给予标准化西医治疗,试验组联用益气温阳活血方剂,比较两组患者的治疗效果.结果 治疗后试验组左室射血分数(LVEF)较对照组更高(P<0.05),而左室收缩末期内径(LVESD)则较对照组更低(P<0.05).治疗后试验组N末端脑利钠肽前体(NT-proBNP)水平与明尼苏达心衰生活质量量表(MLHFQ)评分低于对照组(P<0.05),6 min步行距离长于对照组(P<0.05).治疗后试验组中医证候的主症和次症积分低于对照组(P<0.05).两组不良反应发生率比较差异无统计学意义(P>0.05).结论 在冠状动脉粥样硬化性心脏病合并射血分数降低型心力衰竭经西医标准方案治疗的基础上加入中医益气温阳活血方,能够更好地改善患者的心功能,逆转心室重塑,进而改善患者的生命质量,且联合方案具有良好的安全性.

Objective To explore the impact of Yiqi Wenyang Huoxue Formula combined with standard therapy on ventricular remodeling and quality of life in patients with coronary atherosclerotic heart disease and reduced ejection fraction heart failure.Methods A total of 123 patients with coronary atherosclerotic heart disease combined with reduced ejection fraction heart failure who were admitted to Zunyi Hospital of Traditional Chinese Medicine from October 2022 to October 2023 were selected.They were randomly divided into the experimental group and the control group,with 60 cases in each group.Both groups were given standardized Western medicine treatment.The experimental group was additionally treated with Yiqi Wenyang Huoxue Formula.The therapeutic effects of the two groups were compared.Results After treatment,the left ventricular ejection fraction(LVEF)in the experimental group was higher than that in the control group(P<0.05),while the left ventricular end-systolic diameter(LVESD)was lower in the experimental group than in the control group(P<0.05).After treatment,the level of N-terminal pro-B-type natriuretic peptide(NT-proBNP)in the experimental group was lower than that in the control group,and the score of the Minnesota Heart Failure Quality of Life Scale(MLHFQ)was also lower(P<0.05).The 6-minute walking distance in the experimental group was longer than that in the control group(P<0.05).The total score of the main and secondary symptoms of the traditional Chinese medicine syndrome in the experimental group was lower than that in the control group(P<0.05).There was no statistically significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion On the basis of the standard Western medicine treatment for coronary atherosclerotic heart disease combined with reduced ejection fraction heart failure,the addition of Yiqi Wenyang Huoxue Formula can better improve the patient's cardiac function,reverse ventricular remodeling,thereby improving the patient's quality of life,and the combined treatment regimen has good safety.

陶镇健;文金荣

贵州中医药大学研究生院,贵州遵义 563000遵义市中医院,贵州遵义 563000

医药卫生

冠状动脉粥样硬化性心脏病射血分数降低型心力衰竭心室重塑益气温阳活血方生命质量

Coronary atherosclerotic heart diseaseHeart failure with reduced ejection fractionVentricular remodelingYiqi Wenyang Huoxue FormulaQuality of life

《中国药物经济学》 2026 (6)

79-82,4

10.12010/j.issn.1673-5846.2026.06.015

评论